#Insilico Medicine Hong Kong IPO 2025

Total 2 articles

Digital DNA transforming into data nodes over Hong Kong skyline

Insilico Medicine Hong Kong IPO 2025: 46% Surge Marks New Era for Biotech AI

Insilico Medicine Hong Kong IPO 2025 debuts with a 46% stock jump, raising $300m. The firm eyes expansion into the LLM market to drive future growth.

Dec 31, 2025

Digital laboratory visualizing AI-driven drug discovery for Insilico IPO

TechEN

Taming the Molecular Casino: Insilico Medicine Hong Kong IPO and the Rise of Digital Einstein

Insilico Medicine goes public in Hong Kong, unveiling its 'digital Einstein' AI to tackle the 90% failure rate in the 'molecular casino' of drug discovery.

Dec 30, 2025